BION-1301 Treatment Results in Clinically Meaningful Proteinuria Reductions in Patients with IgAN
Mean reduction in UPCR of 53.8 % at 24 weeks in Cohort 2 with de novo SC administration of BION-1301 are consistent with those observed in Cohort 1
Format
PNG
Source
Chinook Therapeutics, Inc.